Mysoline (Primidone)

Primidone is a pro‑drug that is metabolized in the body to phenobarbital and phenylethylmalonamide. These metabolites enhance the activity of the inhibitory neurotransmitter GABA, increasing neuronal membrane stability and decreasing hyper‑excitability. The resulting effect suppresses abnormal electrical activity that underlies seizures and tremor.

The dosage of Mysoline is individualized by the prescribing healthcare professional based on the patient’s age, weight, type of seizure or tremor, and response to therapy. Physicians typically start with a low dose and adjust gradually to achieve optimal control while monitoring for side effects.

The pregnancy safety category for Primidone is not clearly established. Because potential risks to the fetus cannot be ruled out, the drug should be used during pregnancy only if the expected benefit justifies the potential risk. Breastfeeding mothers should consult their physician, as Primidone can be excreted in breast milk.

To order Mysoline, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements) and assist with import documentation.

Primidone is often compared with phenobarbital, another barbiturate‑derived antiepileptic. While both enhance GABA‑mediated inhibition, Primidone generally has a slower onset and may be better tolerated in some patients. Compared with newer agents such as levetiracetam, Primidone has a longer history of use but may require more monitoring for sedation and hepatic effects.

Mysoline tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the container tightly closed and out of reach of children. Do not store in bathrooms or near heat sources.

Mysoline is taken orally, usually with a glass of water. It can be taken with or without food, but consistent timing each day helps maintain stable blood levels. Patients should follow the prescribing physician’s instructions regarding dose frequency and any titration schedule.

Serious risks include severe skin reactions such as Stevens‑Johnson syndrome, blood dyscrasias like leukopenia or thrombocytopenia, and hepatic dysfunction indicated by jaundice or elevated liver enzymes. Patients should seek immediate medical attention if they notice rash, unexplained bruising, yellowing of the skin or eyes, or persistent fatigue.

Mysoline should be avoided in individuals with known hypersensitivity to Primidone, phenobarbital, or any of the tablet’s excipients. It is also contraindicated in patients with severe hepatic impairment or those with a history of serious skin reactions to related drugs. Pregnant or nursing women should use it only under strict medical supervision.